AASLD: Oral HCV Combo Yields Rapid Response (CME/CE)

SAN FRANCISCO (MedPage Today) — A combination of two investigational antiviral drugs with different mechanisms of action against hepatitis C virus yielded quick and persistent responses in previous nonresponders without the use of pegylated interferon, a researcher said here.

Post a Comment

Comments are closed.